ACG在2025年药厂Pro & Pack展示了AI型制药制造技术,在全球提升了安全和可追踪性。 ACG unveiled AI-powered pharmaceutical manufacturing tech at Pharma Pro&Pack 2025, boosting safety and traceability globally.

ACG在海得拉巴的Pharma Pro & Pack 2025展示了先进的制药制造技术,配有诸如SMARTCOATERTM X2和PROTABTM 700平板印刷机等新设备,用于高效生产。 ACG displayed advanced pharmaceutical manufacturing technologies at Pharma Pro&Pack 2025 in Hyderabad, featuring new equipment like the SMARTCOATER™ X2 and PROTAB™ 700 tablet press for high-efficiency production. 该公司强调了AI动力检查系统“UALISHIeld”和“Verishield”——确保符合全球序列和追踪标准。 The company highlighted AI-powered inspection systems—QualiShield and Verishield—that ensure compliance with global serialisation and traceability standards. 通过ACG生命科学云,这些系统与数字跟踪和追踪工具及患者参与工具相结合,促进了产品安全和透明度。 Integrated with digital track-and-trace and patient engagement tools via the ACG Life Sciences Cloud, these systems boost product safety and transparency. ACG还强调其在Shirwal的流程发展实验室,支持制定和扩大规模。 ACG also emphasized its Process Development Lab in Shirwal, supporting formulation and scale-up. ACG在138个国家有60多年的经验和业务,继续推动全球制药制造业的创新。 With over six decades of experience and operations in 138 countries, ACG continues to drive innovation in global pharmaceutical manufacturing.